 Prevention insulitis diabetes treatment complete Freund adjuvant NOD mice studies immune cell defects autoimmune diabetes complete Freund adjuvant CFA onset diabetes prediabetic nonobese diabetic NOD mice prevalence onset diabetes CFA-injected versus uninjected NOD mice females males incidence identifiable insulitis CFA-treated prediabetic female NOD mice incidence female age-matched controls Mac- splenocytes CFA-treated NOD mice splenocytes diabetic mice incidence diabetes diabetic splenocytes vivo spleen CFA injection sustained increases cell proliferation associated major increase numbers immature cell type surface antigen CFA-treated NOD mice spleen vitro stimulation mitogen cocultured cells splenocytes CFA-treated mice concanavalin A- proliferation spleen thymus untreated NOD mice treatment CFA development diabetes insulitis generation splenic suppressor cells capable diabetogenic T-lymphocyte function vivo vitro